FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

6 results

imlygic
(talimogene laherparepvec)
Amgen Inc
Usage: IMLYGIC is indicated for the local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in melanoma patients with recurrence after surgery. It does not improve overall survival or affect visceral metastases.
mekinist
(trametinib)
Novartis Pharmaceuticals Corporation
Usage: MEKINIST is indicated for treating unresectable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC), locally advanced or metastatic anaplastic thyroid cancer, unresectable or metastatic solid tumors, and low-grade glioma with BRAF V600E/K mutations, in combination with dabrafenib, as per FDA-approved tests.
opdivo
(nivolumab)
E.R. Squibb & Sons, L.L.C.
Usage: OPDIVO is indicated for the treatment of various cancers, including unresectable/metastatic melanoma, neoadjuvant and adjuvant non-small cell lung cancer, metastatic non-small cell lung cancer, malignant pleural mesothelioma, advanced renal cell carcinoma, classical Hodgkin lymphoma, and others. It is used in different combinations and settings based on the cancer type.
opdualag
(nivolumab and relatlimab-rmbw)
E.R. Squibb & Sons, L.L.C.
Usage: OPDUALAG™ is indicated for the treatment of adult and pediatric patients aged 12 and older with unresectable or metastatic melanoma.
tecentriq
(atezolizumab)
Genentech, Inc.
Usage: TECENTRIQ is indicated for treating various cancers, including: non-small cell lung cancer (adjuvant and metastatic), extensive-stage small cell lung cancer, unresectable or metastatic hepatocellular carcinoma, BRAF V600 mutation-positive melanoma, and unresectable or metastatic alveolar soft part sarcoma.
tecentriq hybreza
(atezolizumab and hyaluronidase-tqjs)
Genentech, Inc.
Usage: TECENTRIQ HYBREZA is indicated for treating various cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (ES-SCLC), unresectable or metastatic hepatocellular carcinoma (HCC), BRAF V600 mutation-positive melanoma, and unresectable or metastatic alveolar soft part sarcoma (ASPS) in adults.

Medications for Melanoma

imlygic

mekinist

opdivo

opdualag

tecentriq

tecentriq hybreza